Programme & Replay
COVID-19: Advances and Remaining Challenges
Paris, September 29th - October 1st, 2021

 
Wednesday, September 29, 2021
Opening session
5.30 pm-7.30 pm (GMT+2)
 
 
5.30 pm (GMT+2)

Claire Giry, Director General of Research and Innovation
who is representing French minister of Higher Education, Research and Innovation, Frédérique Vidal (on-site)

Stewart Cole, CEO, Institut Pasteur (on-site)
Soumya Swaminathan, Executive Director, Chief Scientist, World Health Organisation (online)

 


6.15 pm (GMT+2)

The quest to understand the origins of SARS-CoV-2 (on-site)

Marion Koopmans
Erasmus Medical Center, The Netherlands
Thursday, September 30, 2021
Viral evolution and perspectives
09.00 am-10.30 am (GMT+2)
 
Chairs on-site: - Sylvie van der Werf, Institut Pasteur, France - Jean-Claude Manuguerra, Institut Pasteur, France
09.00 am (GMT+2)

Assessing variant-specific changes in epidemiological phenotype and vaccine efficacy (online)

Neil Ferguson
Imperial College, London, United Kingdom
09.30 am (GMT+2)

Population-based studies of vaccine effectiveness and tolerance in Israël (online)

Ran Balicer
Clalit Research Institute, Israel
10.00 am (GMT+2)

Real-time to Real-life: Phylogenetics & SARS-CoV-2 Variant Tracking (on-site)

Emma Hodcroft
Bern University, Switzerland
Morning Break
10.30 am-11.30 am (GMT+2)
 
 
 
Viral entry and replication/neutralisation
11.30 am-1.00 pm (GMT+2)
 
Chairs on-site: - Félix Rey, Institut Pasteur, France - Claude-Agnès Reynaud, Necker, Inserm, France
11.30 am (GMT+2)

Delta variant replication and antiviral immune responses (on-site)

Olivier Schwartz
Institut Pasteur, France
12.00 pm (GMT+2)

Evolution of the spike cleavage site in SARS-CoV-2 enhances airborne transmission (on-site)

Wendy Barclay
Imperial College London, United Kingdom
12.30 pm (GMT+2)

In-situ architecture and neutralization mechanism of SARS-CoV-2 (online)

Sai Li
Tsinghua University, China
Lunch break
1.00 pm-2.00 pm (GMT+2)
 
 
 
Viral persistence and long Covid
2.00 pm-3.30 pm (GMT+2)
 
Chairs on-site: - Olivier Robineau, Centre Hospitalier Tourcoing, France - Darragh Duffy, Institut Pasteur, France
2.00 pm (GMT+2)

Clinical presentation of long Covid (on-site)

Mayssam Nehme
Hôpitaux Universitaires de Genève, Switzerland
2.30 pm (GMT+2)

Long Covid and autoantibodies (online)

Aaron Ring
Yale University, United States
3.00 pm (GMT+2)

Inflammation and dysregulation of brain cell types in severe COVID-19 : links to long-term symptoms (online)

Andrew Chris Yang
Stanford University, United States
Afternoon Break
3.30 pm-4.00 pm (GMT+2)
 
 
 
Patient management and future treatments
4.00 pm-5.30 pm (GMT+2)
 
Chair online: - Evelina Tacconelli, University of Verona, Italy
Chair on-site: - Maya Hites, University Of Brussels, Belgium
4.00 pm (GMT+2)

Choosing an antiviral treatment for SARS-CoV-2 pneumonia (on-site)

Florence Ader
Inserm, France
4.30 pm (GMT+2)

Immunomodulatory therapy for COVID-19 and other severe viral pneumonias (online)

Peter Horby
Oxford University, United Kingdom
5.00 pm (GMT+2)

Future therapeutical strategies (online)

Jesús Rodríguez-Baño
Former President of ECCMID
Friday, October 1, 2021
Evaluation of impact of interventions
09.00 am-10.30 am (GMT+2)
 
Chairs on-site: - Daniel Levy-Bruhl, Santé publique France, France - Vittoria Colizza, Inserm, France
09.00 am (GMT+2)

Optimal COVID-19 quarantine and testing strategies (online)

Jeffrey Townsend
Yale University, United States
09.30 am (GMT+2)

Digital contact tracing: conception, development and evaluation (online)

Christophe Fraser
Oxford University, United Kingdom
10.00 am (GMT+2)

Applying behavioural science to understanding Covid-19 protective behaviours (on-site)

Susan Michie
University College London, United Kingdom
Morning Break
10.30 am-11.00 am (GMT+2)
 
 
 
Children and SARS-CoV-2 transmission and control
11.00 am-12.30 pm (GMT+2)
 
Chairs on-site: - Dominique Costagliola, Inserm, France - Julie Toubiana, Pédiatrie et Infectiologue pédiatrique à Hôpital Necker-Enfants Malades - APHP, France
11.00 am (GMT+2)

Children susceptibility and infectiousness (on-site)

Arnaud Fontanet
Institut Pasteur, France
11.30 am (GMT+2)

COVID impact on physical and mental health of children (online)

Tamsin Ford
University of Cambridge, United Kingdom
12.00 pm (GMT+2)

Impact of self-testing and vaccination of children on schools closing (on-site)

Vittoria Colizza
Inserm, France
Lunch break
12.30 pm-2.00 pm (GMT+2)
 
 
 
Vaccine regimens and effectiveness
2.00 pm-3.30 pm (GMT+2)
 
Chairs on-site: - Odile Launay, Hôpital Cochin APHP, France - Caroline Demangel, Institut Pasteur, France
2.00 pm (GMT+2)

Using Systems Serology to define correlates of immunity to SARS-CoV-2 (online)

Galit Alter
Harvard-T.H. Chan, United States
2.30 pm (GMT+2)

Anticipating the impact of vaccines on epidemic dynamics (on-site)

Simon Cauchemez
Institut Pasteur, France
3.00 pm (GMT+2)

Available and future vaccines (on-site)

Brigitte Autran
Inserm, France
Afternoon Break
3.30 pm-4.00 pm (GMT+2)
 
 
 
Why and how should we get the planet vaccinated?
4.00 pm-5.30 pm (GMT+2)
 
Chairs online: - Maria Van Kerkhove, WHO, - Marie-Paule Kieny, Inserm, France
4.00 pm (GMT+2)

Antigenic variation of SARS-CoV-2 viruses and vaccine strain update strategies (on-site)

Derek Smith
Cambridge University, United Kingdom
4.30 pm (GMT+2)

Challenges of developing, producing and delivering COVID-19 vaccines to the world (online)

Melanie Saville
CEPI, France
5.00 pm (GMT+2)

Global SARS-CoV-2 vaccination: Challenges and Prospects (on-site)

Salim Abdool Karim
CAPRISA, South Africa
Closing lecture
5.30 pm-6.00 pm (GMT+2)
 
 
5.30 pm (GMT+2)

Adaptive immunity and memory to SARS-CoV-2 infection or COVID-19 RNA vaccines (online)

Shane Crotty
La Jolla Institute for Immunology, United States
Closing address
6.00 pm-6.30 pm (GMT+2)
 
 
6.00 pm (GMT+2)

Closing address (Prerecorded)

Rochelle Walensky
Director, US CDC, United States
Closing words
6.30 pm-7.10 pm (GMT+2)
 
 
6.30 pm (GMT+2)

Allocution by Olivier Véran: French Minister for Solidarity and Health (Prerecorded)

Translation
6.40 pm (GMT+2)

Closing Remarks (on-site)

Yazdan Yazdanpanah
ANRS | Maladies infectieuses émergentes / Inserm, France

 

Persistance-webSoft
congresoft.fr
plateforme dédiée aux manifestations
Tel. : 01 84 17 20 55 / 06 89 19 34 06
E-mail : contact@congresoft.fr
La première plateforme Française de gestion de manifestations regroupant la billeterie, la gestion des hébergements, une boutique en ligne, la gestion des surfaces d'exposition et la gestion complète du programme scientifique.
Organisation de Congrès, manifestations, Séminiaires, Colloques